- Home
- EYEN vs GXAI Comparison
EYEN vs GXAI Comparison
Compare EYEN & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- GXAI
- Stock Information
- Founded
- EYEN 2014
- GXAI 2021
- Country
- EYEN United States
- GXAI United States
- Employees
- EYEN N/A
- GXAI N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- GXAI
- Sector
- EYEN Health Care
- GXAI
- Exchange
- EYEN Nasdaq
- GXAI Nasdaq
- Market Cap
- EYEN 9.2M
- GXAI 7.5M
- IPO Year
- EYEN 2018
- GXAI 2023
- Fundamental
- Price
- EYEN $0.08
- GXAI $3.32
- Analyst Decision
- EYEN Hold
- GXAI
- Analyst Count
- EYEN 4
- GXAI 0
- Target Price
- EYEN $2.00
- GXAI N/A
- AVG Volume (30 Days)
- EYEN 18.8M
- GXAI 17.8M
- Earning Date
- EYEN 11-12-2024
- GXAI 11-14-2024
- Dividend Yield
- EYEN N/A
- GXAI N/A
- EPS Growth
- EYEN N/A
- GXAI N/A
- EPS
- EYEN N/A
- GXAI N/A
- Revenue
- EYEN $31,832.00
- GXAI $2,979.00
- Revenue This Year
- EYEN $23,413.60
- GXAI N/A
- Revenue Next Year
- EYEN $400.98
- GXAI N/A
- P/E Ratio
- EYEN N/A
- GXAI N/A
- Revenue Growth
- EYEN 2557.10
- GXAI N/A
- 52 Week Low
- EYEN $0.08
- GXAI $1.01
- 52 Week High
- EYEN $2.57
- GXAI $19.20
- Technical
- Relative Strength Index (RSI)
- EYEN 27.49
- GXAI 57.83
- Support Level
- EYEN $0.08
- GXAI $2.69
- Resistance Level
- EYEN $0.09
- GXAI $4.41
- Average True Range (ATR)
- EYEN 0.01
- GXAI 1.13
- MACD
- EYEN 0.01
- GXAI 0.10
- Stochastic Oscillator
- EYEN 13.08
- GXAI 34.17
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.